Literature DB >> 2502412

Blastomycosis.

S F Davies1, G A Sarosi.   

Abstract

Blastomycosis is the least understood of the major endemic mycoses in North America. The fungus exists in the soil in its mycelial form, and when the proper growth conditions exist growth and spore formation will occur. When microfici containing the growing mycelium of blastomyces are disturbed, an infecting aerosol is formed. The spores are inhaled and eventually settle in the alveoli where multiplication by binary fission occurs. Following development of cell-mediated immunity the infection is localized in the lung. During the pre-immune phase of the infection spread to extrapulmonary sites may occur. Most common sites of involvement include the skin, bones, prostate and central nervous system. Pulmonary disease may resolve spontaneously or progress. Treatment is required for progressive pulmonary illness and all episodes of extrapulmonary disease. For life-threatening blastomycosis or blastomycosis of the central nervous system amphotericin B is the treatment of choice, while ketoconazole is an excellent alternative for patients who are not critically ill or have no central nervous system involvement.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2502412     DOI: 10.1007/bf01964062

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  22 in total

1.  Comparison of the enzyme immunoassay, immunodiffusion, and complement fixation tests in detecting antibody in human serum to the A antigen of Blastomyces dermatitidis.

Authors:  B S Klein; J N Kuritsky; W A Chappell; L Kaufman; J Green; S F Davies; J E Williams; G A Sarosi
Journal:  Am Rev Respir Dis       Date:  1986-01

2.  Exfoliative cytology in the rapid diagnosis of pulmonary blastomycosis.

Authors:  J S Sanders; G A Sarosi; D J Nollet; J I Thompson
Journal:  Chest       Date:  1977-08       Impact factor: 9.410

3.  Primary pulmonary blastomycosis: a laboratory-acquired infection.

Authors:  G L Baum; P I Lerner
Journal:  Ann Intern Med       Date:  1970-08       Impact factor: 25.391

Review 4.  Azole antifungal drugs: old and new.

Authors:  W E Dismukes
Journal:  Ann Intern Med       Date:  1988-08-01       Impact factor: 25.391

5.  The radiological appearance of pulmonary blastomycosis.

Authors:  W Laskey; G A Sarosi
Journal:  Radiology       Date:  1978-02       Impact factor: 11.105

6.  State of the art: histoplasmosis.

Authors:  R A Goodwin; R M Des Prez
Journal:  Am Rev Respir Dis       Date:  1978-05

7.  Endogenous activation in blastomycosis.

Authors:  W Laskey; G A Sarosi
Journal:  Ann Intern Med       Date:  1978-01       Impact factor: 25.391

8.  Treatment of blastomycosis and histoplasmosis with ketoconazole. Results of a prospective randomized clinical trial. National Institute of Allergy and Infectious Diseases Mycoses Study Group.

Authors: 
Journal:  Ann Intern Med       Date:  1985-12       Impact factor: 25.391

9.  Treatment of systemic mycoses with ketoconazole: emphasis on toxicity and clinical response in 52 patients. National Institute of Allergy and Infectious Diseases collaborative antifungal study.

Authors:  W E Dismukes; A M Stamm; J R Graybill; P C Craven; D A Stevens; R L Stiller; G A Sarosi; G Medoff; C R Gregg; H A Gallis; B T Fields; R L Marier; T A Kerkering; L G Kaplowitz; G Cloud; C Bowles; S Shadomy
Journal:  Ann Intern Med       Date:  1983-01       Impact factor: 25.391

10.  Erythema nodosum and blastomycosis.

Authors:  D D Miller; S F Davies; G A Sarosi
Journal:  Arch Intern Med       Date:  1982-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.